Details for Patent: 7,141,581
✉ Email this page to a colleague
Summary for Patent: 7,141,581
| Title: | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| Abstract: | Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds. |
| Inventor(s): | Steven Bender, Dana Hu-Lowe, David Ray Shalinsky |
| Assignee: | Pfizer Corp SRL , Agouron Pharmaceuticals LLC |
| Application Number: | US10/639,890 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 7,141,581
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,141,581
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1218348 | ⤷ Start Trial | C300576 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1218348 | ⤷ Start Trial | PA2013003 | Lithuania | ⤷ Start Trial |
| European Patent Office | 1218348 | ⤷ Start Trial | CA 2013 00010 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
